Italia markets closed

ILMN Jun 2024 160.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5800-0,8200 (-58,57%)
Alla chiusura: 01:39PM EDT
Schermo intero
Chiusura precedente1,4000
Aperto0,9000
Denaro0,4500
Lettera0,6500
Prezzo d'esercizio160,00
Scadenza2024-06-21
Min-Max giorno0,5800 - 0,9000
Contratto - Min-MaxN/D
Volume10
Open Interest329
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera